Pfizer
PFE
Performance
About Pfizer
Pfizer is a global biopharmaceutical company focused on developing and delivering medicines and vaccines to treat a range of diseases and conditions. The organization emphasizes research and product pipelines across areas including vaccines, oncology, internal medicine, and immunology, with activities spanning discovery, clinical trials, manufacturing, and patient access. Pfizer emphasizes science-driven innovation to address root causes of chronic diseases and public health challenges worldwide, with programs and resources aimed at patients, healthcare professionals, and partners. While content highlights United States residents, Pfizer maintains a worldwide footprint and collaborates globally to advance therapies and health outcomes.
Recent News
Free Access to BioWorld Coronavirus Articles
Why Brand Purpose Fails (And the 3 Rules to Make It Work)
Baseline Debuts To Challenge GLP-1 Giant Lilly in Alcohol Use Disorder
TandemAI Closes $22M Series A Extension Round
Stocks Eye Weekly Wins After Impressive April Finish
Berkshire Shares Left Behind as S&P 500 Rallies to Record High
Merck Partners Remepy in PDURS-Focused Alliance
Helical Secures $10 Million Seed Round to Launch Virtual AI Lab for Pharma
Q4 Results Today Live: MobiKwik Q4 Profit Dips Q-O-Q, Tata Power, Dr Reddy's, Torrent Power, Dixon Tech, Max Financial, Berger Paints, Pfizer, Sagility, MTAR Tech, V-Guard, Inox India, Nazara, Texmaco Rail to Announce Q4 Results
Roche Breast Cancer Prospect Fails First-Line Test, Shares Fall
Will Pfizer’s Lyme Disease Gamble Pay Off or Set the Space Back?
Sangamo Therapeutics Inc (SGMO) Q1 2026 Earnings Call Transcript
Biotech in 2025: A Retrospective
FDA Approves Eli Lilly’s Foundayo, Pitting First Oral Obesity Pill Against Novo Nordisk’s Wegovy
Ruder Finn Launches "What's Next" Podcast to Examine the Future of Marketing, Media, and Leadership in an AI Driven Era
Syngene Hires Maninder Kapoor Puri as CHRO, Abhijit Zutshi as CCO
Bristol‑Myers Squibb Seen as Most Undervalued Large‑Cap Healthcare Stock in the S&P 500
Iridius Raises $8.6M Seed Round to Build Compliance-by-Design AI Platform for Regulated Enterprise Workflows
Pfizer’s Early Metsera Data Leaves Analysts Wanting More
Judge Approves Pfizer, SEC Settlement Tied to Insider Trading at Cohen Hedge Fund
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Shows Strong Efficacy in Phase III Trial
Eli Lilly Raises $9 Billion in Record Investment‑Grade Bond Offering to Finance Acquisitions
Pfizer Deals Extend Patent Life for a Top-Selling Rare Disease Drug
Breast Cancer Treatments Heat Up: Six Therapies Poised to Transform Patient Outcomes
Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs
Servier Signs €1bn-Plus AI Pact with Iktos
STAT+: Former Banker Brought on to Revitalize Pfizer’s Strategy Departs His Post
World Hemophilia Day 2026: New Treatment Era and Improving Diagnosis
Pfizer Shares Edge Higher on Strong Oncology Data Amid Flat 2026 Revenue Guidance
Is a ‘Genuinely Held’ Political Belief Enough for a Vaccine Exemption?
In the Clinic for April 30, 2026
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
Eli Lilly to Acquire Kelonia Therapeutics in $7 B Cash Deal
Rigel Signs ~$445M Licensing Pact with Arvinas and Pfizer for Veppanu
Diagonal Therapeutics’ Innovative Clustering Antibodies for Vascular Diseases
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
Brepocitinib Approval May Be ‘Highlight of the Derm-Rheum World’
The Rise of Trispecific Antibodies: Biopharma’s Next Big Bet After Bispecifics
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
AstraZeneca Leads Big Pharma’s AI Clinical Trials Revolution with Real-World Patient Impact
Procedural Complaints: Raising Procedural Issues in CMA Cases
Pfizer, BioNTech to Pause COVID Vaccine Study Due to Low Enrollment
Madrigal Eyes Combination MASH Therapy with Pfizer Deal
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge
Immunotherapy Drug Helps Bladder Cancer Patients Avoid Major Organ Removal
MindImmune Therapeutics Closes $10.2M Series A Extension; Brings Round Total to $30M
Persistent Measles Vaccine Gaps Found Among Emergency Room Patients
STAT+: Pfizer’s Lyme Vaccine Results Set up Tricky Regulatory Path
Dr. Vinay Prasad “Called For” RCTs. Dr. Peter Marks Delivered Them.
Macrocycles: Big Is the New Beautiful
Recent Deals
MindImmune Therapeutics Secures $10.2M Series A Extension, Total Funding Reaches $30M
CellCentric Secures $220M Series D Funding to Advance Multiple Myeloma Drug
Crossbow Therapeutics Raises $77M in Series B Funding
Pfizer and Arvinas Sell Breast Cancer Drug Rights to Rigel for $35M
French Biotech Enodia Therapeutics Raises €20.7M with Pfizer Backing
Mission Therapeutics Raises $13.3M From Existing Strategic Investors
STORM Therapeutics Raises $56M Series C to Advance RNA-Modification Cancer Therapy
FoRx Therapeutics Secures $50M Series A to Advance Precision Cancer Drug